Guangshun Sun

发表

The Effect of Anlotinib Combined with anti-PD-1 in the Treatment of Gastric Cancer

Fan Wu, Hongyong Cao, Jin Zhou, 2022, Frontiers in Surgery.

Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma

X. Kong, Yongxiang Xia, Weiwei Tang, 2022, Frontiers in Immunology.

STK39 enhances the progression of Cholangiocarcinoma via PI3K/AKT pathway

Jindao Wu, Weiwei Tang, Yiwei Lu, 2021, iScience.

Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies

X. Kong, Yongxiang Xia, Zehua Jin, 2022, International journal of biological sciences.

Treatment of patients with cancer using PD-1/PD-L1 antibodies: Adverse effects and management strategies (Review)

Xuesong Shi, X. Kong, Weiwei Tang, 2022, International journal of oncology.

Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing

Weiwei Tang, Guoqiang Sun, Yao-Yao Zhang, 2022, Redox biology.

MGP promotes CD8+ T cell exhaustion by activating the NF-κB pathway leading to liver metastasis of colorectal cancer

Jin-hai Tang, Xuehao Wang, Xiongxiong Pan, 2022, International journal of biological sciences.

Comprehensive Analysis of VCAN Expression Profiles and Prognostic Values in HCC

Xuesong Shi, Wenling Zhang, Weiwei Tang, 2022, Frontiers in Genetics.

Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma.

F. Xiong, Weiwei Tang, Guo-An Shao, 2022, Acta biomaterialia.

Various Uses of PD1/PD-L1 Inhibitor in Oncology: Opportunities and Challenges

Yongxiang Xia, Weiwei Tang, Ye Cheng, 2021, Frontiers in Oncology.

Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer

Wei Jiang, Fan Wu, Weiwei Tang, 2021, OncoTargets and therapy.

Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges

Xuehao Wang, X. Kong, Weiwei Tang, 2021, Frontiers in Cell and Developmental Biology.

Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges

Weiwei Tang, Hongyong Cao, Ye Cheng, 2021, Frontiers in Cell and Developmental Biology.

Upregulation of ADAR Promotes Breast Cancer Progression and Serves as a Potential Therapeutic Target

Weiwei Tang, Hanjin Wang, Ye Cheng, 2021, Journal of oncology.

Application of Animal Models in Cancer Research: Recent Progress and Future Prospects

Fan Wu, Hanjin Wang, Ye Cheng, 2021, Cancer management and research.

Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy

Yongxiang Xia, Weiwei Tang, Jinyu Zhang, 2022, Journal for ImmunoTherapy of Cancer.

Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers

Xuehao Wang, Wei Jiang, Y. Zhong, 2021, Molecular therapy. Nucleic acids.

m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression

Xuehao Wang, Yongxiang Xia, Weiwei Tang, 2021, Molecular therapy. Nucleic acids.

WNT5a in Colorectal Cancer: Research Progress and Challenges

Xuesong Shi, Weiwei Tang, Hongyong Cao, 2021, Cancer management and research.

CMAR_A_289819 2483..2498

Xuesong Shi, Weiwei Tang, Hongyong Cao, 2021 .

Potential molecular mechanisms and clinical progress in liver metastasis of breast cancer.

Yun Hu, Hanjin Wang, Liangliang Wu, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges

Xuesong Shi, Fan Wu, Weiwei Tang, 2021, Molecular therapy oncolytics.

Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer

Huiyu Wang, Jie Mei, Xiaorui Liu, 2019, Biomarker Research.

mRNA microarray profiling identifies a novel circulating HTRA2 for detection of gastric cancer

Wenling Zhang, Xin Chen, Weiwei Tang, 2021, Journal of clinical laboratory analysis.

Inhibition of PARP Potentiates Immune Checkpoint Therapy through miR-513/PD-L1 Pathway in Hepatocellular Carcinoma

Weiwei Tang, Hongyong Cao, Zhouxiao Li, 2022, Journal of oncology.

Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer

Huiyu Wang, Jie Mei, Xiaorui Liu, 2019, Biomarker Research.

GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway

Yongxiang Xia, Weiwei Tang, Ziyi Chen, 2023, Journal for ImmunoTherapy of Cancer.

Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway

Sun Guoqiang, X. Kong, Yongxiang Xia, 2022, Journal of oncology.

CHSY1 promotes CD8+ T cell exhaustion through activation of succinate metabolism pathway leading to colorectal cancer liver metastasis based on CRISPR/Cas9 screening

Weiwei Tang, Guoqiang Sun, Guangshun Sun, 2023, Journal of Experimental & Clinical Cancer Research.

Up-Regulation of VCAN Promotes the Proliferation, Invasion and Migration of HCC and Serves as a Biomarker

Weiwei Tang, Hongyong Cao, Liangliang Wu, 2021 .

Single-cell RNA-sequencing atlas reveals an FABP1-dependent immunosuppressive environment in hepatocellular carcinoma

Yongxiang Xia, Weiwei Tang, Li Liu, 2023, Journal for ImmunoTherapy of Cancer.

Tegaserod Maleate Inhibits Breast Cancer Progression and Enhances the Sensitivity of Immunotherapy

Weiwei Tang, Hanjin Wang, Ye Cheng, 2022, Journal of oncology.